Abstract
Background: The relationship between the heart and the liver is well established. Hyperbilirubinemia, a common complication associated with left ventricular assist device (LVAD) implantation, appears as a result of liver dysfunction and can turn into a life-threatening problem. Previous studies have related these events to intrahepatic cholestasis and centrilobular liver necrosis. In this study we want to observe if there is any difference between the type of pump used and the presence of liver dysfunction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
